Best Peptide Vendors for Third-Party COAs: The Transparency Leaderboard

How We Scored the Leaderboard

Every position on this board is defended by the same five-point scoring rubric: COA availability (is a certificate posted at all?), third-party verification (is the issuing lab independent and named?), testing method depth (does the COA include HPLC purity percentage plus mass spectrometry identity confirmation?), lot-level traceability (does the COA match a specific batch number on the product page?), and policy transparency (does the vendor publish a clear retesting or dispute policy?). Each criterion is worth up to 20 points, for a maximum score of 100.

Vendors were evaluated based on publicly accessible product pages, downloadable COA documents, and stated testing policies as of mid-2025. No vendor paid for placement. A vendor with a COA that lists only a generic purity figure without a named lab or a lot number scores zero on third-party verification and lot-level traceability, regardless of how polished its website looks.

One clarification before the rankings: research peptides sold by these vendors are not FDA-approved drugs. Where a peptide shares a name with an approved pharmaceutical compound, such as semaglutide (sold as Wegovy and Ozempic) or bremelanotide (sold as Vyleesi), the approval belongs to the branded prescription product, not to any research-chemical version. These rankings cover only documentation quality, not safety or efficacy claims.

Positions 1-2: The Top of the Board

Peptide Sciences holds the top spot with a composite score of 94/100. Every product page links to a downloadable COA that names Janoshik Analytical as the issuing laboratory, a Czech Republic-based independent testing house that has become a recognized benchmark in the research peptide space. Each certificate includes an HPLC chromatogram, a purity percentage, and a mass spectrometry result confirming molecular identity. Lot numbers on the COA match the lot numbers printed on physical vials, giving buyers a direct chain of custody. The one deduction comes from the absence of a formal published retesting policy, which costs four points on the policy transparency criterion and two points on COA availability for occasional out-of-stock items that show archived rather than current COAs.

Amino Asylum scores 88/100 and takes the second position. The vendor also uses Janoshik Analytical for the majority of its catalog and posts COAs directly on product pages. HPLC purity data is present on all tested items reviewed, and mass spec confirmation appears on most peptide listings. The gap versus the top spot comes from inconsistency: a small number of product pages during the review period showed COAs dated more than 18 months prior without a note explaining whether the batch was still in circulation. That staleness issue costs points on lot-level traceability. Amino Asylum does publish a clear retest request policy in its FAQ, which earns full marks on the policy transparency criterion.

Positions 3-4: Strong Performers With Noted Gaps

Limitless Life Nootropics scores 81/100 and takes third. The vendor publishes COAs from multiple third-party labs depending on the compound, which actually adds credibility because it signals the vendor is not locked into a single testing relationship. HPLC data is present across the catalog. The main deduction comes from mass spectrometry coverage: roughly a quarter of the product pages reviewed showed COAs with HPLC purity only, without a corresponding mass spec identity confirmation. That gap matters because HPLC alone cannot confirm a compound is what it claims to be, only that something of a certain purity is present. Limitless Life scores full marks on lot traceability and policy transparency.

Core Peptides lands at position four with a score of 76/100. The vendor posts COAs from Janoshik and earns strong marks on third-party verification and HPLC data. The score drops on two fronts. First, the lot number on the COA does not always appear on the product page itself, requiring the buyer to cross-reference the document manually. Second, the retesting policy is not explicitly stated in a findable FAQ or policy page, which costs points on policy transparency. The underlying testing quality is solid, but the documentation presentation needs work to climb the board.

Positions 5-6: Mid-Table and What Holds Them Back

Swiss Chems scores 68/100 and sits fifth. The vendor does publish COAs, and third-party lab names appear on most documents. The score suffers primarily because a portion of the catalog, particularly some of the newer peptide additions, showed COAs that were either missing mass spectrometry data or linked to a generic certificate not tied to a specific lot. Swiss Chems earns points for a clearly written quality assurance page that outlines its testing process, which partially offsets the documentation gaps elsewhere in the catalog.

Behemoth Labz rounds out the ranked positions at sixth with a score of 61/100. COAs are present for most products, and the vendor does name its testing partners. The score is held down by two consistent issues: several product pages link to COAs that open as images rather than structured PDF documents, making lot numbers and chromatogram data harder to read and verify, and the policy transparency criterion scores low because no formal retesting or dispute resolution process is published anywhere on the site. Behemoth Labz has the foundation to move up the board if it addresses those two presentation issues.

What Does a Legitimate COA Actually Contain?

A certificate of analysis is only as useful as the information inside it. A legitimate third-party COA for a research peptide should include the name and contact information of the issuing laboratory, the date of analysis, the lot or batch number that matches the product packaging, an HPLC purity result expressed as a percentage, a mass spectrometry result confirming the molecular weight of the compound, and the name of the compound tested. Documents missing any of those elements leave meaningful gaps in the verification chain.

HPLC, or high-performance liquid chromatography, separates the components of a sample and measures their relative proportions. A result of 99 percent purity means 99 percent of the detectable material in the sample elutes at the expected retention time. Mass spectrometry goes further by measuring the molecular weight of the compound, which confirms identity rather than just purity. Both tests together give a much stronger picture than either alone. Vendors that provide only one of the two are offering partial documentation.

Lot-level traceability is the piece most buyers overlook. A COA dated two years ago for a compound that has been restocked multiple times since then tells you nothing about what is in the current vial. The COA should correspond to the specific batch currently being sold. Vendors that archive old COAs without flagging them as historical records create a transparency problem even if the underlying testing was rigorous when it was done.

Buyers should also note that a COA confirms what a lab found in a sample submitted by the vendor. It does not confirm that every vial in a batch is identical to the tested sample, and it does not constitute a safety or efficacy endorsement. Research peptides are sold for laboratory research purposes, and no COA changes the regulatory status of a compound.

How to Read the Scorecard Before You Buy

Before placing an order, pull up the product page and look for a direct link to the COA, not a general link to a testing page. Click through and check that the issuing lab is named with contact information, not just a logo. Confirm the lot number on the certificate matches whatever lot number appears on the product listing or is stated as the current batch. Check the date: a COA older than 12 to 18 months for a product that has been restocked is a yellow flag worth investigating.

Check the testing methods listed. If the document shows only HPLC without mass spectrometry, the identity of the compound has not been independently confirmed, only its purity relative to other detectable material. If the document is an image file with no readable metadata, consider whether the data can be independently verified. A PDF from a named laboratory with a report number is a stronger document than a JPEG with no traceable origin.

Finally, look for a stated policy on what happens if a customer disputes a result or requests a retest. Vendors that publish this process openly are signaling confidence in their testing. Vendors that have no stated policy leave buyers with no recourse if a question arises. That policy gap is one of the most common reasons otherwise strong vendors lose points on this leaderboard.